LAB Act Language Included in Consolidated Appropriations Bill

Dec. 17, 2019

Language from the The Laboratory Access for Beneficiaries Act (LAB Act, H.R. 3584) has been included in the Consolidated Appropriations Bill, released December 16. The LAB Act was introduced in the U.S. House of Representatives by Reps. Peters (D-CA), Bilirakis (R-FL), Pascrell (D-NJ), Holding (R-NC), Schrader (D-OR) and Hudson (R-NC). If passed this legislation would take an important step by providing a one-year delay of  data reporting activities required by the Protecting Access to Medicare Act of 2014 (PAMA). This delay would: 
  • Allow for a more representative share of laboratories to report data; and
  • Provide valuable time for stakeholders and policymakers to determine how to reform (PAMA) and ensure a system that will protect Medicare beneficiary access.
In addition to a delay of the data reporting period, the LAB Act would commission a study conducted by a neutral third party, the National Academy of Medicine, to assess how to improve PAMA implementation to better reflect Congress’ original intent of a market-based fee schedule.